Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

Correction to: Genetics in Medicine 2020; https://doi.org/10.1038/s41436-020-0814-5, published online 13 May 2020

The original version of this Article omitted an essential reference (“Meulemans L, Mesman RLS, Caputo SM, et al. Skipping nonsense to maintain function: the paradigm of BRCA2 exon 12. Cancer Res. 2020;80(7):1374–1386. DOI: 10.1158/0008-5472.CAN-19-2491”). This has now been added in both the PDF and HTML versions of the Article.

In addition, the original version of this Article contained a typo in the sentence “However, two variants in respectively the splice acceptor site (c.517–2A>G) and donor site (c.631+2T>G) of exon 7 were classified as pathogenic based...” that was incorrectly given as “However, two variants in respectively the splice donor site (c.517–2A>G) and acceptor site (c.631+2T>G) of exon 7 were classified as pathogenic based...”. Where “donor” should be “acceptor” and vice versa. This has now been corrected in both the PDF and HTML versions of the Article.

Finally, the original version of this Article contained an incorrect supplementary file. This has now been replaced in the HTML version of the Article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Maaike P. G. Vreeswijk PhD.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mesman, R.L.S., Calléja, F.M.G.R., de la Hoya, M. et al. Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2. Genet Med 22, 1427–1428 (2020). https://doi.org/10.1038/s41436-020-0883-5

Download citation